InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-25 · accession 0001960780-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-27 2026-01-25 ALT Jordt Raymond M Chief Business Off M - OptEx $0.00 +14.6K 57.8K +34% $0
D 2026-01-27 2026-01-25 ALT Jordt Raymond M Chief Business Off F - Tax $5.50 -3,855 53.9K -7% -$21.2K
D 2026-01-27 2026-01-25 ALT Jordt Raymond M Chief Business Off M - OptEx $0.00 -14.6K 29.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2026-01-25 M A 14,600 $0.00 57,770 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
2 Common Common Stock, par value $0.0001 2026-01-25 F D 3,855 $5.50 53,915 D — —
3 Derivative Restricted Stock Units 2026-01-25 M D 14,600 $0.00 29,200 D — · — to — 14,600 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.